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Benign enlargement of the subarachnoid space (BESS) is the most 
common cause of macrocephaly in infants. This study aimed to 
evaluate the neurodevelopmental outcomes in infants with BESS.
Materials & Methods
In this follow-up study, all records of infants diagnosed with BESS 
in 2012-2016 were assessed. A clinical follow-up examination 
was carried out at 6, 12, 18, and 24 months of age to assess the 
macrocephaly outcomes. Denver Developmental Screening Test-II 
(DDST-II) was used for evaluating the psychomotor development of 
infants at 24 months of age. All data were entered in SPSS Version 
13, and descriptive statistics were measured.
Results
Out of 32 infants included in this study, 28 (87.5%) were boys. Five 
cases of prematurity history (15.6%), and 23 cases of macrocephaly in 
the family (71.9%) were recorded. The mean age of BESS diagnosis 
was 6.8 months (SD=3.2). subdural hematoma was reported in one 
infant (3.1%). Also, 28 infants showed macrocephaly at 18 months of 
age (83.3%). Seven patients had developmental delay, according to 
DDST-II (22%). The mean head circumference at birth and six months 
of age was significantly greater in infants with developmental delay 
compared to those with normal development. There was a significant 
difference between the mean head circumference at birth (P=0.05) 
and the mean head circumference at six months of age (P=0.02).
Conclusion 
Developmental delay is frequent in BESS infants, especially those 
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Introduction
Benign enlargement of the subarachnoid space 
(BESS), also called benign external hydrocephalus, 
is the most common cause of macrocephaly in 
infants (1). BESS, as a subgroup of hydrocephaly, is 
defined as macrocephaly, combined with increased 
cerebrospinal fluid (CSF) in the subarachnoid 
space. Mild ventriculomegaly may also be seen on 
neuroimaging (3). Cerebro-Venous hypertension 
is a frequent cause of BESS. The arachnoid villi 
immaturity results in the impairment of CSF 
absorption, causing Cerebro-Venous hypertension 
(3). In infants with opened fontanels and sutures, 
accumulation of CSF would result in widening 
of subarachnoid spaces fostered by the growing 
skull (2) This clinical condition occurs in 0.4 per 
1000 live births (4). there are few studies on the 
developmental outcomes of BESS in infants (5، 8). 
The aim of this study is evaluation of developmental 
outcome in infants with BESS.
Materials & Methods
In this follow-up study, after obtaining approval 
from the Ethics Committee of Isfahan University 
of Medical Sciences (ethical approval code: 
IR.MUI.REC.1396.3.583), all infants (<1 year) 
with macrocephaly or other symptoms, who were 
referred to the pediatric neurology clinic of Isfahan 
University of Medical Sciences and diagnosed 
with BESS during 2012-2016, were enrolled. On 
the other hand, patients with known neurological 
with macrocephaly at birth and six months of age, and requires 
medical attention.
Keywords: Benign enlargement of the subarachnoid space; 
Development; External hydrocephalus; Infant; Macrocephaly
DOI: 10.22037/ijcn.v15i1.25309
diseases and complications (i.e., brain hemorrhage 
and need for shunts) were excluded from the study. 
Variables, such as age of BESS diagnosis 
(months), gender, head circumference (HC) 
at birth and admission, neurological signs and 
symptoms, prematurity history, and family history 
of macrocephaly, were recorded in this study. 
Macrocephaly was defined as HC more than two 
standard deviations (SDs) above the mean for age 
and sex. A clinical follow-up examination was 
carried out at the age of 6, 12, 18, and 24 months to 
assess HC. All patients were examined at 24 months 
of age in terms of the developmental status, using 
Denver Developmental Screening Test (DDST-II). 
DDST-II was used for the evaluation of 
psychomotor development at the age of 24 months. 
This test was used for the assessment of child 
development from birth until six years of age. The 
DDST was developed by Frankenburg in 1967 and 
validated in many studies (10). DDST-II evaluates 
four general areas: (1) personal-social (25 items); 
(2) fine motor-adaptive (29 items); (3) language 
(39 items); and (4) gross motor (32 items) (5, 11). 
In the present study, the results of the test were 
interpreted as either normal development (the child 
performs the task successfully, or the parents report 
that the child can do it) or abnormal development 
(there is at least one failure in one of the items, 
or the child doesn’t perform the skill, or the 
parents report that the child cannot do it). Previous 
studies have used DDST-II for the developmental 
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evaluation of children with BESS (5, 12-14). 
The mean and SD were measured to describe the 
quantitative data, and percentages were calculated 
to describe the qualitative data. Chi-square test 
and Fisher’s exact test were used to determine 
differences between variables. Student’s t-test was 
used for mean comparisons of quantitative data. 
P-value less than 0.05 was considered statistically 
significant. SPSS Version 13 (SPSS Inc., Chicago, 
Illinois, USA) was used for data analysis. 
Results
During the study, 37 infants were referred to the 
clinic and diagnosed with BESS. Two infants were 
excluded from the study, one of whom underwent 
shunting, and the other one was diagnosed with 
Sotos syndrome during the follow-up. Also, three 
infants were lost to follow-up during the study; 
one child expired due to respiratory failure, and 
the parents of two infants were uncooperative. 
Finally, 32 infants were enrolled in the study and 
analyzed. The mean age of BESS diagnosis was 
6.8±3.2 months. Twenty-eight infants with BESS 
were male (87.5%), and five infants had a history 
of prematurity (15.6%). Also, 72% of cases had a 
family history of macrocephaly. Table 1 presents 
the characteristics of infants with BESS. 
One of the infants (a 13-month-old boy) 
developed a bulging fontanel, the sunset eye sign, 
and irritability. Brain imaging and laboratory 
examinations were unrevealing, and no definite 
etiological factor was determined as the cause 
of pseudotumor cerebri. We could not perform 
cerebrospinal fluid (CSF) manometry because of 
parental reluctance. The patient’s clinical signs 
and symptoms improved with four weeks of 
acetazolamide treatment. A subdural hematoma 
was reported in one infant (3.1%). Also, a four-
month-year-old boy with macrocephaly showed 
head lag and subdural hematoma at 13 months of 
age. He was treated observationally and showed 
normal development at the age of two. 
Table 2 presents the infants’ mean HC at birth and 
at 6, 12, and 18 months of age, based on gender. 
Twenty-eight infants (83.3%) had macrocephaly at 
the age of 18 months. Seven infants (22%) showed 
developmental delay, based on the DDST-II results. 
Five patients showed delay in two or more areas of 
DDST-II (Table 2).
Table 3 shows the relationship between the 
developmental outcomes of BESS patients. In 
both genders, the mean HC at birth and six months 
of age was significantly higher in infants with 
developmental delay as compared to those with 
normal development. There was a significant 
difference in the mean HC at birth (P=0.05) and at 
six months of age (P=0.02).
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Table 1. The characteristics of infants with BESS
Variables Number Percentage (%)




Prematurity history 5 15.6
Family history of macrocephaly 23 71.9
Cause of referral 
Macrocephaly 30 93.8
Head lag 1 3.1
Head trauma 1 3.1
Medical history 
Seizure 1 3.1
Table 2. The outcome findings of infants with BESS
Variables Number Percentage (%)
Complications 
subdural hematoma  1 3.1
Growth and developmental delay 7 22
Gross motor delay 5 15.6
Fine motor delay 4 12.5
Personal-social delay 5 15.6
Language delay 5 15.6
Affected areas of DDST-II
One area 2 6.2
Two areas 1 3.1
Three areas 1 3.1
Four areas 3 9.4
Macrocephaly at 6 months 23 71.8
Macrocephaly at 12 months 29 90.6
Macrocephaly at 18 months 28 83.3
Macrocephaly at 24 months 28 83.3
37
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HC at birth (mean±SD) (boys) 35.6±2.2
HC at 6 months (mean±SD) (boys) 46.1±1.7
HC at 12 months (mean±SD) (boys) 49.1±1.4
HC at 18 months (mean±SD) (boys) 50.5±1.6
HC at birth (mean±SD) (girls) 35.7±0.5
HC at 6 months (mean±SD) (girls) 46.1±2.5
HC at 12 months (mean±SD) (girls) 49.6±1.6
HC at 18 months (mean±SD) (girls) 51.3±1.1
HC: Head circumference.
Table 3. Comparison of infants with BESS and developmental outcomes
Variables Delay (%)  Normal (%) P-value 
Age at BESS diagnosis (mean±SD) 7.2±3.7 6.5±3.1 0.6
HC at birth (mean±SD) 37.1±3 35.2±1.2 0.05
HC at 6 months (mean±SD) 45.8±1.1 47.8±3.3 0.02
HC at 12 months (mean±SD) 50.2±2 48.9±1.2 0.09
HC at 18 months (mean±SD) 51.2±2 51.7±2 0.1
HC at BESS diagnosis (mean±SD) 47.5±3 46.3±2 0.3
Prematurity history 1 (14.3) 4 (16) 0.7
Family history of macrocephaly 5 (71.4) 18 (72) 0.6
 Male gender 6 (85.7) 22 (88) 0.6
HC: Head circumference.
Discussion
Macrocephaly is the main characteristic of BESS 
in a healthy child and is also the main cause of 
presentation to pediatric neurology clinics (1, 4, 
15). In the present study, most of the patients were 
referred to the clinic due to macrocephaly. The 
increase in HC occurs around the age of six months 
(5, 16) and is generally steady before the age of 
18 months (15, 17). Statistics show that 11-87% 
of BESS cases remain with macrocephaly (12, 
18). The present study showed that the mean HC 
of BESS infants, regardless of gender, was above 
the 97th percentile at 6 and 12 months of age, and 
83% of cases had HC above the 97th percentile at 
18 months.
One infant in our study showed a subdural hematoma 
as a BESS complication. Overall, subdural 
hematoma (brain hemorrhage) is the most serious 
complication of BESS in infants (19-22); it may 
occur spontaneously or after a minor trauma (22, 
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delay and head size. They reported developmental 
delay in 28% of infants with macrocephaly versus 
18% of cases without macrocephaly; they did not 
observe any relationship between the head size and 
developmental delay (7). It should be noted that in 
our study, we compared HC at birth, at 6, 12, and 
18 months of age, and at BESS diagnosis, whereas 
Yew et al. only measured HC at diagnosis (eight 
months of age).
Several hypotheses have been proposed to explain 
the cause of developmental delay in children with 
BESS. Theoretically, the high pressure excreted 
on the brain tissue due to increased CSF in the 
subarachnoid space during infancy may create 
inappropriate conditions during the critical 
period of development. Also, the excess CSF 
pressure may cause cortical hypoperfusion and 
lead to persistent and irreversible developmental 
problems (19). Another hypothesis is that the early 
onset of macrocephaly in infants makes it harder 
to develop head control, resulting in motor delay. 
Finally, coexistence of megalencephaly (even 
its benign form) and macrocephaly (15) or the 
associated conditions has been proposed (19, 24). 
Nevertheless, our findings can be alarming for the 
management and follow-up of BESS infants with 
macrocephaly at birth or the first months of life to 
identify the associated conditions or other causes 
of macrocephaly; however, further research with a 
large sample size is needed to test this hypothesis. 
In Conclusion
According to the results of this study and previous 
research, in contrast to the traditional view, BESS 
is not always a benign condition. Developmental 
delay is frequent in BESS infants, especially those 
with macrocephaly at birth or six months of age, 
and requires attention.
23). Our study showed that 7 (22%) patients had 
developmental delay, according to the DDST-
II results at the age of two. Five infants showed 
developmental delays in more than two areas 
of DDST-II. Previous studies have reported 
developmental delays, especially in gross motor 
function (5, 7, 9, 11, 12). Yew et al. reported that 20 
out of 99 infants with BESS (20%) had gross motor 
delays, four infants had verbal delays, and four 
infants showed fine motor delays (7). Moreover, 
Alper et al. reported that two out of 16 infants with 
BESS had fine motor delay, according to DDST-II 
at 20 months of age (12). 
Furthermore, Amouian et al. reported 11 (26.8%) 
cases of development delay, including eight cases of 
motor delay (9). Also, a study by Nickel described 
nine BESS infants, seven of whom had gross 
motor delays at diagnosis (11). Moreover, Alvarez 
et al. reported 36 cases of BESS, 17 of whom 
showed gross motor delays (5). Muenchberger et 
al. also showed that two infants had motor delays 
at 12 months of age, and four out of 15 infants 
had developmental delays at 20 months (motor 
delay in one infant, fine motor delay in one infant, 
and language delay in two infants) (8). However, 
according to most previous studies, developmental 
delays are transient and improve until the age of 
3-4 years (5, 7, 11). 
In the current study, we compared HC (at birth, at 6, 
12, and 18 months of age, and at BESS diagnosis), 
prematurity, family history of macrocephaly, and 
male gender in two groups of infants with delayed 
and normal development. Our findings showed that 
the mean HC at birth and at six months of age was 
significantly larger in the developmental delay group 
compared to the normal development group. So far, 
only one study has evaluated this finding. Yew et 
al. evaluated the relationship between gross motor 
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